Annual EBIT:
-$463.93M-$61.66M(-15.33%)Summary
- As of today, PCVX annual earnings before interest & taxes is -$463.93 million, with the most recent change of -$61.66 million (-15.33%) on December 31, 2024.
- During the last 3 years, PCVX annual EBIT has fallen by -$363.86 million (-363.60%).
- PCVX annual EBIT is now -1477.45% below its all-time high of -$29.41 million, reached on December 31, 2018.
Performance
PCVX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$226.22M-$45.43M(-25.13%)Summary
- As of today, PCVX quarterly earnings before interest & taxes is -$226.22 million, with the most recent change of -$45.43 million (-25.13%) on June 30, 2025.
- Over the past year, PCVX quarterly EBIT has dropped by -$73.24 million (-47.87%).
- PCVX quarterly EBIT is now -2023.32% below its all-time high of -$10.65 million, reached on June 30, 2019.
Performance
PCVX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$604.01M-$73.24M(-13.80%)Summary
- As of today, PCVX TTM earnings before interest & taxes is -$604.01 million, with the most recent change of -$73.24 million (-13.80%) on June 30, 2025.
- Over the past year, PCVX TTM EBIT has dropped by -$89.51 million (-17.40%).
- PCVX TTM EBIT is now -4322.36% below its all-time high of -$13.66 million, reached on March 31, 2019.
Performance
PCVX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PCVX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -15.3% | -47.9% | -17.4% |
| 3Y3 Years | -363.6% | -366.1% | -323.1% |
| 5Y5 Years | -823.5% | -1013.3% | -627.0% |
PCVX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -363.6% | at low | -294.4% | at low | -247.0% | at low |
| 5Y | 5-Year | -823.5% | at low | -990.9% | at low | -627.0% | at low |
| All-Time | All-Time | -1477.5% | at low | -2023.3% | at low | -4322.4% | at low |
PCVX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$226.22M(-25.1%) | -$604.01M(-13.8%) |
| Mar 2025 | - | -$180.79M(-215.2%) | -$530.77M(-14.3%) |
| Dec 2024 | -$463.93M(-15.3%) | -$57.36M(+58.9%) | -$464.45M(+14.4%) |
| Sep 2024 | - | -$139.63M(+8.7%) | -$542.75M(-5.5%) |
| Jun 2024 | - | -$152.98M(-33.6%) | -$514.50M(-15.3%) |
| Mar 2024 | - | -$114.47M(+15.6%) | -$446.20M(-10.9%) |
| Dec 2023 | -$402.27M(-80.0%) | -$135.66M(-21.8%) | -$402.27M(-16.7%) |
| Sep 2023 | - | -$111.39M(-31.5%) | -$344.66M(-18.4%) |
| Jun 2023 | - | -$84.68M(-20.1%) | -$291.19M(-14.2%) |
| Mar 2023 | - | -$70.54M(+9.6%) | -$255.03M(-14.1%) |
| Dec 2022 | -$223.48M | -$78.05M(-34.8%) | -$223.56M(-28.4%) |
| Sep 2022 | - | -$57.92M(-19.3%) | -$174.07M(-21.9%) |
| Jun 2022 | - | -$48.53M(-24.2%) | -$142.77M(-21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$39.06M(-36.8%) | -$117.91M(-15.6%) |
| Dec 2021 | -$100.07M(-12.2%) | -$28.56M(-7.3%) | -$101.99M(-8.3%) |
| Sep 2021 | - | -$26.61M(-12.4%) | -$94.17M(-6.3%) |
| Jun 2021 | - | -$23.67M(-2.3%) | -$88.57M(-3.9%) |
| Mar 2021 | - | -$23.14M(-11.6%) | -$85.22M(+4.5%) |
| Dec 2020 | -$89.21M(-77.6%) | -$20.74M(+1.3%) | -$89.21M(-7.4%) |
| Sep 2020 | - | -$21.02M(-3.4%) | -$83.09M(-13.2%) |
| Jun 2020 | - | -$20.32M(+25.1%) | -$73.38M(-15.2%) |
| Mar 2020 | - | -$27.14M(-85.7%) | -$63.71M(-26.8%) |
| Dec 2019 | -$50.23M(-70.8%) | -$14.61M(-29.2%) | -$50.23M(-41.0%) |
| Sep 2019 | - | -$11.31M(-6.1%) | -$35.62M(-46.5%) |
| Jun 2019 | - | -$10.65M(+22.0%) | -$24.31M(-78.0%) |
| Mar 2019 | - | -$13.66M | -$13.66M |
| Dec 2018 | -$29.41M | - | - |
FAQ
- What is Vaxcyte, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual EBIT year-on-year change?
- What is Vaxcyte, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly EBIT year-on-year change?
- What is Vaxcyte, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. TTM EBIT year-on-year change?
What is Vaxcyte, Inc. annual earnings before interest & taxes?
The current annual EBIT of PCVX is -$463.93M
What is the all-time high annual EBIT for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual earnings before interest & taxes is -$29.41M
What is Vaxcyte, Inc. annual EBIT year-on-year change?
Over the past year, PCVX annual earnings before interest & taxes has changed by -$61.66M (-15.33%)
What is Vaxcyte, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of PCVX is -$226.22M
What is the all-time high quarterly EBIT for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly earnings before interest & taxes is -$10.65M
What is Vaxcyte, Inc. quarterly EBIT year-on-year change?
Over the past year, PCVX quarterly earnings before interest & taxes has changed by -$73.24M (-47.87%)
What is Vaxcyte, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of PCVX is -$604.01M
What is the all-time high TTM EBIT for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high TTM earnings before interest & taxes is -$13.66M
What is Vaxcyte, Inc. TTM EBIT year-on-year change?
Over the past year, PCVX TTM earnings before interest & taxes has changed by -$89.51M (-17.40%)